Fat-Burning Peptide Fragment | Modified HGH Sequence | For Research Use Only

AOD-9604 is a modified fragment of human growth hormone (HGH), specifically the 176–191 amino acid region, which is responsible for the lipolytic (fat-burning) action of HGH without its other growth-related effects. This peptide has become a focus of research for obesity, fat metabolism, and metabolic disorders, offering a targeted approach to adipose tissue reduction without altering glucose or IGF-1 levels.

It mimics the natural fat-burning activity of HGH while avoiding side effects linked to full-length HGH peptides.

🔍 Key Features

• Promotes Fat Breakdown – Activates lipolysis and inhibits lipogenesis in adipose tissue

• No Impact on IGF-1 or Blood Sugar – Unlike full HGH, does not stimulate insulin resistance

• Targeted Anti-Obesity Research – Useful in models focused on weight loss and body composition

• Tissue-Specific Action – Primarily affects abdominal and visceral fat stores in research models

• No Muscle Growth Effect – Purely metabolic, not anabolic

⚙️ Peptide Details

• Peptide Name: AOD-9604 (Fragment 176–191)

• CAS Number: 221231-10-3

• Molecular Formula: C₇₈H₁₂₃N₂₃O₂₅S₂

• Molecular Weight: ~1815.1 g/mol

• Sequence: Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe

• Purity: ≥ 98% (HPLC Verified)

• Form: Lyophilised white/off-white powder

• Unit Size: 5mg per vial

🧊 Storage & Handling

• Storage (lyophilised): Store at –20°C, dry and protected from light

• Reconstitution: Use bacteriostatic water or sterile saline

• Post-Reconstitution: Store at 2–8°C and use within 7 days

• Avoid: Repeated freeze-thaw cycles

⚠️ For Research Use Only

AOD-9604 – 5mg is offered exclusively for laboratory and scientific research. It is not approved for human or veterinary use. Must be handled by qualified professionals in controlled research environments.